Speakers

 

Ana Filipa Alexandre, Global Director, Health Economics Outcomes Research, Astellas Pharma

Ana Filipa Alexandre | Global Director, Health Economics Outcomes Research | Astellas Pharma » speaking at World EPA Congress

Abdulrahman AlMesnid, Health Economic Evaluation Lead, Ministry of Health

Abdulrahman AlMesnid | Health Economic Evaluation Lead | Ministry of Health » speaking at World EPA Congress

John Alter, VP, Patient and Health Impact Lead, Hospital Business Unit, Pfizer

John Alter | VP, Patient and Health Impact Lead, Hospital Business Unit | Pfizer » speaking at World EPA Congress

Ines Alves, President, ANDO Portugal

Ines Alves | President | ANDO Portugal » speaking at World EPA Congress

Luigi Angelillo, Associate Director, HEOR & New Products Market Access (EMEA), Santen GmbH

Luigi Angelillo | Associate Director, HEOR & New Products Market Access (EMEA) | Santen GmbH » speaking at World EPA Congress

Glenn Anley, Global Director Pricing & Access - Covid Therapeutics, GSK

Glenn Anley | Global Director Pricing & Access - Covid Therapeutics | GSK » speaking at World EPA Congress

Ad Antonisse, Director Market Access & External Affairs, AstraZeneca BV

Ad Antonisse | Director Market Access & External Affairs | AstraZeneca BV » speaking at World EPA Congress

Marnix Artz, Head of Patient Access, Pricing & Public Affairs, Netherlands, Merck Group

Marnix Artz | Head of Patient Access, Pricing & Public Affairs, Netherlands | Merck Group » speaking at World EPA Congress

Dragana Atanasijevic, Head of HTA Department, Institute of Public Health of Serbia

Dragana Atanasijevic | Head of HTA Department | Institute of Public Health of Serbia » speaking at World EPA Congress

Nico Bacharidis, Founder, growpal

Nico Bacharidis | Founder | growpal » speaking at World EPA Congress

Alex Bastian, Vice President, Value And Market Access, Galapagos NV

Alex Bastian | Vice President, Value And Market Access | Galapagos NV » speaking at World EPA Congress

Tomer Ben Zaken, Pricing And Alliance Manager, Takeda

Tomer Ben Zaken | Pricing And Alliance Manager | Takeda » speaking at World EPA Congress

Jennifer Cain Birkmose, Vice President, Global Head Of Patient Access And Community Engagement, Swedish Orphan Biovitrum

Jennifer Cain Birkmose | Vice President, Global Head Of Patient Access And Community Engagement | Swedish Orphan Biovitrum » speaking at World EPA Congress

Jesper Bjerggren, European Market Access Lead Respiratory/Digital Health, Teva Pharmaceuticals

Jesper Bjerggren | European Market Access Lead Respiratory/Digital Health | Teva Pharmaceuticals » speaking at World EPA Congress

Maria Alejandra Blanc, Director - Regulatory Affairs – Region South, Abbvie

Maria Alejandra Blanc | Director - Regulatory Affairs – Region South | Abbvie » speaking at World EPA Congress

Nadia Bodkin, OLM DEI Expert, Rare Advocacy Movement

Nadia Bodkin | OLM DEI Expert | Rare Advocacy Movement » speaking at World EPA Congress

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Axel Boehnke | Director Market Access EU North | PTC Therapeutics » speaking at World EPA Congress

Luc Boileau, Chief Executive Officer, INESSS

Luc Boileau | Chief Executive Officer | INESSS » speaking at World EPA Congress

Amanda Bok, CEO, European Haemophilia Consortium

Amanda Bok | CEO | European Haemophilia Consortium » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Public Policy, EMEA & APAC, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Public Policy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Vidya Breeveld, Head Public affairs & Market Access, Sanofi

Vidya Breeveld | Head Public affairs & Market Access | Sanofi » speaking at World EPA Congress

Line Brøns, Senior health economist, Amgros I/S

Line Brøns | Senior health economist | Amgros I/S » speaking at World EPA Congress

Hassan Bruneo, Head of Market Access, Pricing & Policy, Canada/Europe/MEA, Alnylam Pharmaceuticals

Hassan Bruneo | Head of Market Access, Pricing & Policy, Canada/Europe/MEA | Alnylam Pharmaceuticals » speaking at World EPA Congress

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics | Project Advisor | Mechanism of Coordinated Access to orphan medicinal products (MoCA) » speaking at World EPA Congress

Nicki Catterick, VP, Head of Global Market Access & Pricing | Neurology & Immunology, Merck Group

Nicki Catterick | VP, Head of Global Market Access & Pricing | Neurology & Immunology | Merck Group » speaking at World EPA Congress

Sandro Cesaro-Tadic, Head Strategic Product Pricing, Roche

Sandro Cesaro-Tadic | Head Strategic Product Pricing | Roche » speaking at World EPA Congress

Lung-I Cheng, Head of Global Value & Access, Cell Therapies, Oncology Business Unit, Takeda

Lung-I Cheng | Head of Global Value & Access, Cell Therapies, Oncology Business Unit | Takeda » speaking at World EPA Congress

Helene Chevrou-Severac, HEOR RWE Centre of Excellence Head, International & Japan, Alexion

Helene Chevrou-Severac | HEOR RWE Centre of Excellence Head, International & Japan | Alexion » speaking at World EPA Congress

José Luis Sánchez Chorro, Associate Director Market Access Spain, GW Pharmaceuticals

José Luis Sánchez Chorro | Associate Director Market Access Spain | GW Pharmaceuticals » speaking at World EPA Congress

Ali Ciger, Commercial Director, Pain, Pfizer

Ali Ciger | Commercial Director, Pain | Pfizer » speaking at World EPA Congress

Francesca Cook, Vice President, Pricing and Marketing Access, RegenxBio

Francesca Cook | Vice President, Pricing and Marketing Access | RegenxBio » speaking at World EPA Congress

Margarida Costa, Global Pricing & Market Access Manager, Galderma

Margarida Costa | Global Pricing & Market Access Manager | Galderma » speaking at World EPA Congress

Warren Cowell, Director Market Access UK, Shionogi Ltd

Warren Cowell | Director Market Access UK | Shionogi Ltd » speaking at World EPA Congress

Sarah Creviston, Vice President, Global Patient Advocacy & Government Affairs, Novartis Gene Therapies

Sarah Creviston | Vice President, Global Patient Advocacy & Government Affairs | Novartis Gene Therapies » speaking at World EPA Congress

Mike Crosher, Managing Director, Chugai Pharma UK

Mike Crosher | Managing Director | Chugai Pharma UK » speaking at World EPA Congress

Charles-Etienne de Cidrac, Director Of Health Insurance, AXA

Charles-Etienne de Cidrac | Director Of Health Insurance | AXA » speaking at World EPA Congress

Carla Deakin, Programme Director - Commercial And Managed Access, NICE

Carla Deakin | Programme Director - Commercial And Managed Access | NICE » speaking at World EPA Congress

Gilles Ducorroy, Global Head of RWE Services, Novartis

Gilles Ducorroy | Global Head of RWE Services | Novartis » speaking at World EPA Congress

Dominik Dziurda, Head Of Health Services Division, AOTMiT

Dominik Dziurda | Head Of Health Services Division | AOTMiT » speaking at World EPA Congress

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at World EPA Congress

Gina Ewy, Head of Global Market Access, Hansa Biopharma

Gina Ewy | Head of Global Market Access | Hansa Biopharma » speaking at World EPA Congress

Jonathan Galduf, Director Market Access and Public Affairs (Iberia), CSL Behring

Jonathan Galduf | Director Market Access and Public Affairs (Iberia) | CSL Behring » speaking at World EPA Congress

Benjamin Gannon, Head of Int’l Access & Policy, Guardant Health

Benjamin Gannon | Head of Int’l Access & Policy | Guardant Health » speaking at World EPA Congress

Philippe Ghyssels, VP, Corporate and Global Public Affairs, Ipsen

Philippe Ghyssels | VP, Corporate and Global Public Affairs | Ipsen » speaking at World EPA Congress

Ramiro Gilardino, Head, Value & Access Communications, Healthcare Consultancy Group

Ramiro Gilardino | Head, Value & Access Communications | Healthcare Consultancy Group » speaking at World EPA Congress

Christoph Glatzer, Head of Global Market Access, Pricing, RWE, PRO, Johnson & Johnson

Christoph Glatzer | Head of Global Market Access, Pricing, RWE, PRO | Johnson & Johnson » speaking at World EPA Congress

Josie Godfrey, Co-Founder and CEO, Realise Advocacy

Josie Godfrey | Co-Founder and CEO | Realise Advocacy » speaking at World EPA Congress

Wim Goettsch, Special Hta-Advisor, Zorginstituut

Wim Goettsch | Special Hta-Advisor | Zorginstituut » speaking at World EPA Congress

Sylvie Greneche, Global Head of Market Access, General Medicines, Sanofi

Sylvie Greneche | Global Head of Market Access, General Medicines | Sanofi » speaking at World EPA Congress

Marcus Guardian, Chief Operating Officer, EUnetHTA

Marcus Guardian | Chief Operating Officer | EUnetHTA » speaking at World EPA Congress

Laura Guarga, Consultant of Pharmacoeconomic Department, CatSalut

Laura Guarga | Consultant of Pharmacoeconomic Department | CatSalut » speaking at World EPA Congress

Diego Guarin, Executive Director, Regional Market Access Latin America, Global Market Access, Merck

Diego Guarin | Executive Director, Regional Market Access Latin America, Global Market Access | Merck » speaking at World EPA Congress

Josep Maria Guiu Segura, Head of Pharmacy, Pharmacy and Medicines Area, Consorci De Salut I Social De Catalunya

Josep Maria Guiu Segura | Head of Pharmacy, Pharmacy and Medicines Area | Consorci De Salut I Social De Catalunya » speaking at World EPA Congress

Sanjay Gupta, Vice President, Head of Global RWE & US HEOR, Eisai

Sanjay Gupta | Vice President, Head of Global RWE & US HEOR | Eisai » speaking at World EPA Congress

Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceuticals

Clare Hague | Therapy Area Market Access Lead, Hematology | Janssen Pharmaceuticals » speaking at World EPA Congress

Thomas Hasmann, Vice President, Head of Market Access, Kyowa Kirin International

Thomas Hasmann | Vice President, Head of Market Access | Kyowa Kirin International » speaking at World EPA Congress

Tanja Heidbrede, Head RWE Central EU, UCB

Tanja Heidbrede | Head RWE Central EU | UCB » speaking at World EPA Congress

Ramon Hernandez Vecino, Global Head of Development Real World Evidence, Sanofi

Ramon Hernandez Vecino | Global Head of Development Real World Evidence | Sanofi » speaking at World EPA Congress

Phillip Hivale, Head of US Market Access and Value Communications, Healthcare Consultancy Group

Phillip Hivale | Head of US Market Access and Value Communications | Healthcare Consultancy Group » speaking at World EPA Congress

Birgit Holz, Global Head of Contracting Innovation, Sanofi

Birgit Holz | Global Head of Contracting Innovation | Sanofi » speaking at World EPA Congress

Bill Hu, Professor of Finance, Arkansas State University

Bill Hu | Professor of Finance | Arkansas State University » speaking at World EPA Congress

Wills Hughes-Wilson, Chief Patient Access & Commercial Planning, Mereo Biopharma

Wills Hughes-Wilson | Chief Patient Access & Commercial Planning | Mereo Biopharma » speaking at World EPA Congress

Dawn Ireland, President, CDH International

Dawn Ireland | President | CDH International » speaking at World EPA Congress

Shrividya Iyer, Executive Director, Global RWE & US HEOR, Eisai

Shrividya Iyer | Executive Director, Global RWE & US HEOR | Eisai » speaking at World EPA Congress

Daniel Jackson, Global Head of Market Access Policy, UCB

Daniel Jackson | Global Head of Market Access Policy | UCB » speaking at World EPA Congress

Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen

Ulrike Jacobi | Head Of External Affairs And Market Access | Amgen » speaking at World EPA Congress

Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Saira Jan | Vice-President & Chief Pharmacy Officer | Blue Cross Blue Shield of New Jersey » speaking at World EPA Congress

Yonghua Jing, Director, Real World Evidence & Analytics, Health Economics & Outcomes Research, AbbVie

Yonghua Jing | Director, Real World Evidence & Analytics, Health Economics & Outcomes Research | AbbVie » speaking at World EPA Congress

Elizabeth Johnson, Co-founder, National Association of Medication Access & Patient Advocacy

Elizabeth Johnson | Co-founder | National Association of Medication Access & Patient Advocacy » speaking at World EPA Congress

Navin Joshi, Head of Pricing & Market Access, GlaxoSmithKline

Navin Joshi | Head of Pricing & Market Access | GlaxoSmithKline » speaking at World EPA Congress

Marcela Junqueira, Oncology Market Access Director - Latin America, Janssen Pharmaceutical

Marcela Junqueira | Oncology Market Access Director - Latin America | Janssen Pharmaceutical » speaking at World EPA Congress

Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical

Madhusudan Kabra | Director, Evidence Generation | Otsuka Pharmaceutical » speaking at World EPA Congress

Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, Roche

Gomathi Kaliappan | Health Systems Strategy Leader - Global Access | Roche » speaking at World EPA Congress

Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator Applications

Lisette Kaskens | Senior Global Market Access Manager | Advanced Accelerator Applications » speaking at World EPA Congress

Alison Keetley, Head of Market Access South East Asia, Johnson & Johnson

Alison Keetley | Head of Market Access South East Asia | Johnson & Johnson » speaking at World EPA Congress

Sigrid Klaar, Medical advisor, The Dental and Pharmaceutical Benefits Agency T.L.V.

Sigrid Klaar | Medical advisor | The Dental and Pharmaceutical Benefits Agency T.L.V. » speaking at World EPA Congress

Jelle Kleijn, Global Head of Acanthamoeba Keratitis, SIFI

Jelle Kleijn | Global Head of Acanthamoeba Keratitis | SIFI » speaking at World EPA Congress

Jolanda Koenders, Head Of Patient Value And Access, Takeda

Jolanda Koenders | Head Of Patient Value And Access | Takeda » speaking at World EPA Congress

Adam Kundzewicz, Global Head of Tech Partnerships, Boehringer Ingelheim

Adam Kundzewicz | Global Head of Tech Partnerships | Boehringer Ingelheim » speaking at World EPA Congress

Diane Langenbacher, Partner, Kautz5 gUG

Diane Langenbacher | Partner | Kautz5 gUG » speaking at World EPA Congress

GAEL LE ROUZO, Global Market Access Director, Eusa Pharma

GAEL LE ROUZO | Global Market Access Director | Eusa Pharma » speaking at World EPA Congress

Jost Leemhuis, Head Of Safety Science, Roche

Jost Leemhuis | Head Of Safety Science | Roche » speaking at World EPA Congress

Giovanny Leon, Pricing & Access Regional Director - LatAm & Canada, Novartis AG

Giovanny Leon | Pricing & Access Regional Director - LatAm & Canada | Novartis AG » speaking at World EPA Congress

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at World EPA Congress

Gavin Lewis, Global Head of Market Access, Amgen

Gavin Lewis | Global Head of Market Access | Amgen » speaking at World EPA Congress

Nanxin (Nick) Li, Global/US Market Access Lead, uniQure

Nanxin (Nick) Li | Global/US Market Access Lead | uniQure » speaking at World EPA Congress

Edmund Lim, Executive Director, We CARE Journey

Edmund Lim | Executive Director | We CARE Journey » speaking at World EPA Congress

Sara Lopes, Senior Director, Global Market Access & Pricing Governance, Shionogi BV

Sara Lopes | Senior Director, Global Market Access & Pricing Governance | Shionogi BV » speaking at World EPA Congress

Catarina Lopes Pereira, Global Market Access Manager, Medac

Catarina Lopes Pereira | Global Market Access Manager | Medac » speaking at World EPA Congress

Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Elena Lungu | Manager of Policy Development, Patented Medicine Prices Review Board | Government of Canada » speaking at World EPA Congress

Joerg Mahlich, Market Access and Government Affairs Lead, Miltenyi Biomedicine GmbH

Joerg Mahlich | Market Access and Government Affairs Lead | Miltenyi Biomedicine GmbH » speaking at World EPA Congress

Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita

Marco Marchetti | Director Of The National Center For Health Technology Assessment | Istituto Superiore di Sanita » speaking at World EPA Congress

Canter Martin, EVP and Managing Director, Healthcare Consultancy Group

Canter Martin | EVP and Managing Director | Healthcare Consultancy Group » speaking at World EPA Congress

Suzanne Mcgurn, President and CEO, CADTH

Suzanne Mcgurn | President and CEO | CADTH » speaking at World EPA Congress

Erin Mistry, SVP, Head of Payer Strategy, Gov’t Affairs and Trade Relations, CorMedix Inc

Erin Mistry | SVP, Head of Payer Strategy, Gov’t Affairs and Trade Relations | CorMedix Inc » speaking at World EPA Congress

Vladimir Mladov, HTA Manager, BIOCAD

Vladimir Mladov | HTA Manager | BIOCAD » speaking at World EPA Congress

Suzanne Morgan, Director, Patient Access Services and National Accounts, NS Pharma, Inc.

Suzanne Morgan | Director, Patient Access Services and National Accounts | NS Pharma, Inc. » speaking at World EPA Congress

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Paolo Morgese | EU Director Market Access & Member Relations | Alliance for Regenerative Medicine » speaking at World EPA Congress

Thomas Mueller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany

Thomas Mueller | Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology | Federal Ministry of Health Germany » speaking at World EPA Congress

Michael Muller, Head Of Market Access, Western Europe, Sun Pharma

Michael Muller | Head Of Market Access, Western Europe | Sun Pharma » speaking at World EPA Congress

Diane Munch, Head of Global Pricing, Patient & Health Impact, Pfizer

Diane Munch | Head of Global Pricing, Patient & Health Impact | Pfizer » speaking at World EPA Congress

Bogdan Muresan, Associate Director Global HEOR, Teva Pharmaceutical Europe

Bogdan Muresan | Associate Director Global HEOR | Teva Pharmaceutical Europe » speaking at World EPA Congress

Nuriya Musina, Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme, Ministry of Health Russian Federation

Nuriya Musina | Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme | Ministry of Health Russian Federation » speaking at World EPA Congress

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at World EPA Congress

Claudia Neuber, Head of Global Pricing, AstraZeneca

Claudia Neuber | Head of Global Pricing | AstraZeneca » speaking at World EPA Congress

Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical

Enkeleida Nikai | Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea) | Janssen Pharmaceutical » speaking at World EPA Congress

Declan Noone, President, European Haemophilia Consortium

Declan Noone | President | European Haemophilia Consortium » speaking at World EPA Congress

Laura O'Hanlon, Director, Hereditary Cancer - International, Myriad genetics

Laura O'Hanlon | Director, Hereditary Cancer - International | Myriad genetics » speaking at World EPA Congress

Melvin Olson, Global Head IE Strategy and Innovation, NOVARTIS

Melvin Olson | Global Head IE Strategy and Innovation | NOVARTIS » speaking at World EPA Congress

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski | Chief Operating Officer | Lancaster Cancer Centre » speaking at World EPA Congress

Mario Ouwens, Group Director Medical & Payer Evidence Statistics, AstraZeneca

Mario Ouwens | Group Director Medical & Payer Evidence Statistics | AstraZeneca » speaking at World EPA Congress

Melissa Paige, Associate Director, Payer/Market Access Marketing, NS Pharma, Inc.

Melissa Paige | Associate Director, Payer/Market Access Marketing | NS Pharma, Inc. » speaking at World EPA Congress

Elena Panitti, Global Head Real World Evidence Excellence, Novartis

Elena Panitti | Global Head Real World Evidence Excellence | Novartis » speaking at World EPA Congress

Julien Patris, Director Market Access & Policy – Europe / Canada / MEA (CEMEA), Alnylam

Julien Patris | Director Market Access & Policy – Europe / Canada / MEA (CEMEA) | Alnylam » speaking at World EPA Congress

Ajinkya Pawar, Director, Real World Investigator, Dupilumab | Respiratory, Sanofi

Ajinkya Pawar | Director, Real World Investigator, Dupilumab | Respiratory | Sanofi » speaking at World EPA Congress

Mitchell Payne, Global Head, Value and Access Excellence, Novartis Oncology

Mitchell Payne | Global Head, Value and Access Excellence | Novartis Oncology » speaking at World EPA Congress

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer-Ingelheim » speaking at World EPA Congress

Diogo Teixeira Pereira, Policy Analyst - Office for International Relations and Development, Infarmed

Diogo Teixeira Pereira | Policy Analyst - Office for International Relations and Development | Infarmed » speaking at World EPA Congress

Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company

Ed Pezalla | Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy | Aetna; a CVS Pharmacy Health Company » speaking at World EPA Congress

Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director And Director Of Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at World EPA Congress

Diogo Piedade, Market Access Manager, Medicines for Europe

Diogo Piedade | Market Access Manager | Medicines for Europe » speaking at World EPA Congress

Carme Pinyol, Head Of Pricing And Market Access Southern Europe, Pierre Fabre

Carme Pinyol | Head Of Pricing And Market Access Southern Europe | Pierre Fabre » speaking at World EPA Congress

Lara Pippo, Head Of Market Access, Italy, CSL Behring

Lara Pippo | Head Of Market Access, Italy | CSL Behring » speaking at World EPA Congress

Ana Plata, Global Head of Pricing, UCB

Ana Plata | Global Head of Pricing | UCB » speaking at World EPA Congress

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Mary Lynne Van Poelgeest-Pomfret | President | President of the World Federation for Incontinence and Pelvic Pain - WFIP » speaking at World EPA Congress

Angelina Irizari Policarpio, Head of U.S. HEOR and RWE Communications Team (Market Access), Eisai

Angelina Irizari Policarpio | Head of U.S. HEOR and RWE Communications Team (Market Access) | Eisai » speaking at World EPA Congress

Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche

Sreeram Ramagopalan | Global Head Real-World Evidence (Market Access) | Roche » speaking at World EPA Congress

Andrea Rappagliosi, Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM, Edwards Lifesciences

Andrea Rappagliosi | Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM | Edwards Lifesciences » speaking at World EPA Congress

Marco Rauland, Vice President Global Market Access & Pricing - Strategic Planning, Merck Group

Marco Rauland | Vice President Global Market Access & Pricing - Strategic Planning | Merck Group » speaking at World EPA Congress

Laurene Redding, Head, Value, Access & Policy, Canada, BeiGene

Laurene Redding | Head, Value, Access & Policy, Canada | BeiGene » speaking at World EPA Congress

Vijay Reddy, Senior Director - Global Market Access Strategy - Biologics, Biocon Biologics

Vijay Reddy | Senior Director - Global Market Access Strategy - Biologics | Biocon Biologics » speaking at World EPA Congress

Trevor Richter, Director Access and Reimbursement, Canada, Gilead Sciences

Trevor Richter | Director Access and Reimbursement, Canada | Gilead Sciences » speaking at World EPA Congress

Kevin Rieger, Head Of Public And Governmental Affairs Dach, Ipsen Pharma Gmbh

Kevin Rieger | Head Of Public And Governmental Affairs Dach | Ipsen Pharma Gmbh » speaking at World EPA Congress

Andre Roeder, Head Global Market Access, TETEC AG

Andre Roeder | Head Global Market Access | TETEC AG » speaking at World EPA Congress

Juan Roman, Vice President, Global Market Access, HEOR and Pricing, Krystal Biotech

Juan Roman | Vice President, Global Market Access, HEOR and Pricing | Krystal Biotech » speaking at World EPA Congress

Igor Rudychev, Vice President, Enterprise Analytics, Horizon Therapeutics

Igor Rudychev | Vice President, Enterprise Analytics | Horizon Therapeutics » speaking at World EPA Congress

Alric Ruether, Head, International Affairs, IQWiG

Alric Ruether | Head, International Affairs | IQWiG » speaking at World EPA Congress

Sandrine Ruiz, Global Pricing & Market Access Director, AstraZeneca

Sandrine Ruiz | Global Pricing & Market Access Director | AstraZeneca » speaking at World EPA Congress

Claus Runge, Global Head of Market Access, Public Affairs & Sustainability, Bayer

Claus Runge | Global Head of Market Access, Public Affairs & Sustainability | Bayer » speaking at World EPA Congress

Marika Russo, Market Access Director, Region Europe, NOVARTIS

Marika Russo | Market Access Director, Region Europe | NOVARTIS » speaking at World EPA Congress

Marcelo Sal, Head of Market Access and Pricing, South Cone of South America, PTC Therapeutics

Marcelo Sal | Head of Market Access and Pricing, South Cone of South America | PTC Therapeutics » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access And Trade | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Gustavo Saraiva Dos Anjos, Global Payer Strategy Director, Biologics, GlaxoSmithKline

Gustavo Saraiva Dos Anjos | Global Payer Strategy Director, Biologics | GlaxoSmithKline » speaking at World EPA Congress

Michael Schroter, Co-Head Sustainable Healthcare Equity, HSBC

Michael Schroter | Co-Head Sustainable Healthcare Equity | HSBC » speaking at World EPA Congress

Michael Seewald, VP, Global Evidence, Medical BioPharmaceuticals, AstraZeneca

Michael Seewald | VP, Global Evidence, Medical BioPharmaceuticals | AstraZeneca » speaking at World EPA Congress

Ayman Semaan, Head of Market Access, Biologix

Ayman Semaan | Head of Market Access | Biologix » speaking at World EPA Congress

Maja Sercic, Policy & Science Manager, Medicines for Europe

Maja Sercic | Policy & Science Manager | Medicines for Europe » speaking at World EPA Congress

Jonas Sertorio, Innovation and HTA Consultant, Ministry of Health - Brazil

Jonas Sertorio | Innovation and HTA Consultant | Ministry of Health - Brazil » speaking at World EPA Congress

Raja Shankar, Innovation Lead, AI-Led Strategic Transformation, IQVIA

Raja Shankar | Innovation Lead, AI-Led Strategic Transformation | IQVIA » speaking at World EPA Congress

Rita Shorjian, Business Unit Director – Gulf Countries, Specialty, HCV & Oncology, Abbvie

Rita Shorjian | Business Unit Director – Gulf Countries, Specialty, HCV & Oncology | Abbvie » speaking at World EPA Congress

Tamir Singer, Head of Commercial Development, NHS England

Tamir Singer | Head of Commercial Development | NHS England » speaking at World EPA Congress

Matt Slabbert, Global Lead – Public Affairs, Cell & Gene Therapy, Bayer

Matt Slabbert | Global Lead – Public Affairs, Cell & Gene Therapy | Bayer » speaking at World EPA Congress

Valeriia Sokolova, Health Economics Manager, BIOCAD

Valeriia Sokolova | Health Economics Manager | BIOCAD » speaking at World EPA Congress

Lotte Steuten, Vice President And Head Of Consulting, Office of Health Economics

Lotte Steuten | Vice President And Head Of Consulting | Office of Health Economics » speaking at World EPA Congress

Pernille Storm, Head of Global Pricing, H. Lundbeck A/S

Pernille Storm | Head of Global Pricing | H. Lundbeck A/S » speaking at World EPA Congress

Teddy Sun, Senior Manager, Value Strategy & Payer Engagement, Novo Nordisk

Teddy Sun | Senior Manager, Value Strategy & Payer Engagement | Novo Nordisk » speaking at World EPA Congress

Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation

Monika Szkultecka-Debek | Vice President | Qualitas Vitae Institute Foundation » speaking at World EPA Congress

Giovanni Tafuri, Director, International Pricing & Reimbursement and Policy Strategy, Apellis Pharmaceuticals

Giovanni Tafuri | Director, International Pricing & Reimbursement and Policy Strategy | Apellis Pharmaceuticals » speaking at World EPA Congress

Francesca Tavella, Global payer analytics lead, AstraZeneca

Francesca Tavella | Global payer analytics lead | AstraZeneca » speaking at World EPA Congress

Sam Taylor, Emerging Markets Strategic Pricing Lead, Pfizer

Sam Taylor | Emerging Markets Strategic Pricing Lead | Pfizer » speaking at World EPA Congress

Kris Thiruvillakkat, Sr Director, Global Evidence Market Access Pricing, CSL Behring

Kris Thiruvillakkat | Sr Director, Global Evidence Market Access Pricing | CSL Behring » speaking at World EPA Congress

Gwilym Thompson, Group Director Worldwide Health Economics and Outcomes Research, Markets (ROW), BMS

Gwilym Thompson | Group Director Worldwide Health Economics and Outcomes Research, Markets (ROW) | BMS » speaking at World EPA Congress

Daria Tolkacheva, Head of Health Technology Assessment, JSC BIOCAD

Daria Tolkacheva | Head of Health Technology Assessment | JSC BIOCAD » speaking at World EPA Congress

Jörg Tomeczkowski, Associate Director, Global HTA Decision Support, Janssen

Jörg Tomeczkowski | Associate Director, Global HTA Decision Support | Janssen » speaking at World EPA Congress

Ly Tran, Deputy Secretary, Scientific Advisory Council (Medicines Committee), Zorginstituut

Ly Tran | Deputy Secretary, Scientific Advisory Council (Medicines Committee) | Zorginstituut » speaking at World EPA Congress

Sheela Upadhyaya, Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist, National Institute for Health and Care Excellence

Sheela Upadhyaya | Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist | National Institute for Health and Care Excellence » speaking at World EPA Congress

Andreas Uttenweiler, Head Patient Value Access & Public Affairs, Takeda Pharma AG

Andreas Uttenweiler | Head Patient Value Access & Public Affairs | Takeda Pharma AG » speaking at World EPA Congress

Inneke Van De Vijver, Strategic Advisor - Reimbursement Pharmaceuticals, R.I.Z.I.V. I.N.A.M.I. National Health Insurance Agency

Inneke Van De Vijver | Strategic Advisor - Reimbursement Pharmaceuticals | R.I.Z.I.V. I.N.A.M.I. National Health Insurance Agency » speaking at World EPA Congress

Erik Van Den Berg, Chief Executive Officer, A.M. Pharma

Erik Van Den Berg | Chief Executive Officer | A.M. Pharma » speaking at World EPA Congress

Bart Van Den Daele, Head of External Affairs – Director Market Access - Belux, Gilead Sciences

Bart Van Den Daele | Head of External Affairs – Director Market Access - Belux | Gilead Sciences » speaking at World EPA Congress

Goedele Van Haasteren, Staff Member, Swiss Federal Office of Public Health

Goedele Van Haasteren | Staff Member | Swiss Federal Office of Public Health » speaking at World EPA Congress

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, CZ

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani | Medical Advisor | CZ » speaking at World EPA Congress

Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Kärt Veliste | Chief Specialist at Department of Medicines and Medical Devices | Haigekassa Estonia » speaking at World EPA Congress

Mihaela Veringa, Senior Manager Global Access Policy & Govt. Affairs, Sobi

Mihaela Veringa | Senior Manager Global Access Policy & Govt. Affairs | Sobi » speaking at World EPA Congress

Chris Wasden, Head of HappifyDTx, HAPPIFY HEALTH

Chris Wasden | Head of HappifyDTx | HAPPIFY HEALTH » speaking at World EPA Congress

David Watson, Executive Director, Economic, Health and Commercial Policy, ABPI

David Watson | Executive Director, Economic, Health and Commercial Policy | ABPI » speaking at World EPA Congress

Keith White, Head, Global Market Access, Amylyx Pharmaceuticals

Keith White | Head, Global Market Access | Amylyx Pharmaceuticals » speaking at World EPA Congress

Anne Willemsen, Senior Project Manager, Zorginstituut Nederland / EUnetHTA

Anne Willemsen | Senior Project Manager | Zorginstituut Nederland / EUnetHTA » speaking at World EPA Congress

Scott Williams, Head, Global Public Affairs Rare Diseases and Rare Blood Disorders, Sanofi Genzyme

Scott Williams | Head, Global Public Affairs Rare Diseases and Rare Blood Disorders | Sanofi Genzyme » speaking at World EPA Congress

Leung-Ming Yu, Senior Advisor, HTA and reimbursement, Norwegian Medicines Agency

Leung-Ming Yu | Senior Advisor, HTA and reimbursement | Norwegian Medicines Agency » speaking at World EPA Congress

Natasa Zibelnik, Global Head of Value, Access and Pricing, Eusa Pharma

Natasa Zibelnik | Global Head of Value, Access and Pricing | Eusa Pharma » speaking at World EPA Congress

Fabrizio Zucca, Director Market Access DACH, Alnylam Pharmaceuticals

Fabrizio Zucca | Director Market Access DACH | Alnylam Pharmaceuticals » speaking at World EPA Congress

 

 

DOWNLOAD AGENDA

Get Involved 
 

Connect  

 

 

To Sponsor Or Exhibit


David Boore 
david.boore@terrapinn.com   
+44 20 7092 1047

To Speak


Chris Shanks
Chris.Shanks@terrapinn.com  
+44 20 7092 1070